Meeting Abstract
Autorenliste: Denton, Christopher; Khanna, Dinesh; Jahreis, Angelika; van Laar, Jacob M.; Cheng, Sabrina; Spotswood, Helen; Pope, Janet E.; Allanore, Yannick; Mueller-Ladner, Ulf; Siegel, Jeffrey; Furst, Daniel E.
Jahr der Veröffentlichung: 2016
Seiten: 47-48
Zeitschrift: Rheumatology
Bandnummer: 55
ISSN: 1462-0324
eISSN: 1462-0332
Konferenz: Annual Meeting of the British-Society-for-Rheumatology, British-Health-Professionals-in-Rheumatology and the British-Society-for-Paediatric-and-Adolescent-Rheumatology (Rheumatology)
Verlag: Oxford University Press
Zitierstile
Harvard-Zitierstil: Denton, C., Khanna, D., Jahreis, A., van Laar, J., Cheng, S., Spotswood, H., et al. (2016) SUBCUTANEOUS TOCILIZUMAB IN ADULTS WITH SYSTEMIC SCLEROSIS: 24 AND 48 WEEK SAFETY AND EFFICACY DATA FROM THE FASSCINATE TRIAL, Rheumatology, 55, pp. 47-48
APA-Zitierstil: Denton, C., Khanna, D., Jahreis, A., van Laar, J., Cheng, S., Spotswood, H., Pope, J., Allanore, Y., Mueller-Ladner, U., Siegel, J., & Furst, D. (2016). SUBCUTANEOUS TOCILIZUMAB IN ADULTS WITH SYSTEMIC SCLEROSIS: 24 AND 48 WEEK SAFETY AND EFFICACY DATA FROM THE FASSCINATE TRIAL. Rheumatology. 55, 47-48.
